Related Experiment Videos

Modification of morphine-induced analgesia and toxicity by pertussis toxin

K Lutfy1, S C Chang, J Candido

  • 1College of Pharmacy and Allied Health Professions, St. John's University, Queens, NY 11439.

Brain Research
|March 29, 1991
PubMed

Insights

Pertussis toxin (PTX) significantly reduces morphine

Area of Science:

  • Pharmacology
  • Neuroscience
  • Toxicology

Background:

  • Pertussis toxin (PTX) is known to affect G protein signaling pathways.
  • Opioid analgesia and lethality are complex physiological responses.
  • The role of PTX-sensitive factors in opioid effects requires further investigation.

Purpose of the Study:

  • To investigate the impact of pertussis toxin (PTX) on morphine-induced analgesia and lethality in mice.
  • To determine if PTX alters the dose-response relationship for morphine's effects.
  • To elucidate the involvement of PTX-sensitive pathways in opioid pharmacology.

Main Methods:

  • Mice received intracerebroventricular or intrathecal injections of PTX or saline.
  • Following a 16-day period, mice were assessed for morphine-induced analgesia (tail flick test) and lethality.
  • Pentobarbital-induced mortality was also evaluated to control for general toxicity.

Main Results:

  • PTX treatment decreased morphine analgesic potency approximately 4-fold.
  • Conversely, PTX treatment increased morphine lethal potency by approximately 10-fold.
  • PTX did not affect the lethal potency of pentobarbital, indicating specificity.

Conclusions:

  • Morphine analgesia appears to be mediated by PTX-sensitive G proteins.
  • Morphine-induced lethality may be regulated by PTX-sensitive factors, as PTX enhances its lethal effects.
  • PTX might unmask excitatory opioid receptor-mediated effects contributing to increased morphine lethality.

Related Concept Videos